ACTIVE

DR. VANDEKERCKHOVE HANS, cardioloog en DR. VANDERSTRAETEN EVELYNE, klinisch-bioloog

Financial year 2024 · Closed on 31/12/2024

Net result377,4 k €+67,6 %over 1 year
Gross margin584,8 k €+59,2 %over 1 year
Equity1,1 M €+48,7 %over 1 year

Identity

Source · BCE/KBO

DR. VANDEKERCKHOVE HANS, cardioloog en DR. VANDERSTRAETEN EVELYNE, klinisch-bioloog is a Private limited company incorporated in 2007. Its main activity is: Specialist medical practice activities. Its registered office is in Gent.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0891.656.167
Incorporation
27/08/2007
Legal form
Private limited company
Registered office
Brandweerstraat 21 box 303
9000 Gent · FlandreSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2024
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 17 filings

Trend over 17 financial years

20242023202220212020
Income statement
Gross margin584,8 k €367,3 k €355,2 k €318,2 k €128 k €
EBITDA581 k €366,8 k €354,9 k €317 k €127 k €
Operating result563 k €355,7 k €336 k €299,1 k €102,9 k €
Net result377,4 k €225,2 k €219,6 k €198,2 k €73,3 k €
Balance sheet
Equity1,1 M €771,7 k €614,4 k €396,3 k €213,1 k €
Total assets1,3 M €915,6 k €708 k €514,7 k €555,1 k €
Cash785,3 k €432,5 k €204,9 k €146,8 k €384,1 k €
Debts155,2 k €143,9 k €93,6 k €118,4 k €342 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2024

2 active

Active mandates

DirectorMandates in this companyPeriod
Evelyne VANDERSTRAETEN
Directorsince 13/12/2021Associateended
Hans VANDEKERCKHOVE
DirectorManagerended

Other companies at this address

Brandweerstraat 21 9000 Gent
CompanyCBE no.
Long Gamma● Active
0537.976.252
LUMIARES● Active
0793.928.766
0793.473.163

Full financial information

Source · NBB
202420232022202120202019
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202401/01/202301/01/202201/01/202101/01/202001/01/2019
Closing of the financial year31/12/202431/12/202331/12/202231/12/202131/12/202031/12/2019
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date30/08/202530/08/202430/09/202317/10/202228/09/202111/09/2020
General meeting28/08/202529/08/202429/09/202315/10/202217/09/202107/09/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 17 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202428/08/202530/08/2025DutchPDF
Abridged model31/12/202329/08/202430/08/2024DutchPDF
Abridged model31/12/202229/09/202330/09/2023DutchPDF
Abridged model31/12/202115/10/202217/10/2022DutchPDF
Abridged model31/12/202017/09/202128/09/2021DutchPDF
Abridged model31/12/201907/09/202011/09/2020DutchPDF
Abridged model31/12/201830/06/201930/08/2019DutchPDF
Abridged model31/12/201730/06/201831/08/2018DutchPDF
Abridged model31/12/201630/06/201729/08/2017DutchPDF
Abridged model31/12/201530/06/201603/08/2016DutchPDF
Abridged model31/12/201430/06/201528/07/2015DutchPDF
Abridged model31/12/201330/06/201430/09/2014DutchPDF
Abridged model31/12/201230/06/201322/08/2013DutchPDF
Abridged model31/12/201130/06/201227/09/2012DutchPDF
Abridged model31/12/201030/09/201130/09/2011DutchPDF
Abridged model31/12/200930/06/201015/10/2010DutchPDF
Abridged model31/12/200829/10/200929/10/2009DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

2 active

Active mandates

DirectorMandates in this companyPeriod
Evelyne VANDERSTRAETEN
Directorsince 13/12/2021Associateended
Hans VANDEKERCKHOVE
DirectorManagerended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates21/12/2021
    WIJZIGING RECHTSVORM - BENAMING - MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares06/09/2018
    KAPITAAL - AANDELEN
    PDF
  • Capital / shares29/01/2014
    KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Registered office14/12/2011
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Other04/09/2007
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings17 filings
Mandates
Evelyne VANDERSTRAETEN
20072008200920102011201220132014201520162017201820192020202120222023202420252026
DR. VANDEKERCKHOVE HANS, cardioloog en DR. VANDERSTRAETEN EVELYNE, klinisch-bioloog
Brandweerstraat 21 bte 303, 9000 Gent
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Brandweerstraat 21 bte 303, 9000 GentCurrent
accounts 2021 → 2024
Accounts 2024 · 2025-00470155

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
DR. VANDEKERCKHOVE HANS, cardioloog en DR. VANDERSTRAETEN EVELYNE, klinisch-bioloogCurrent
accounts 2023 → 2024
Accounts 2024 · 2025-00470155
DR. VANDEKERCKHOVE HANS, cardioloog en DR. VANDERSTREAETEN EVELYNE, klinisch bioloog
accounts 2022
Accounts 2022 · 2023-00463655
DR. VANDEKERCKHOVE HANS EN DR. VANDERSTREAETEN EVELYNE
accounts 2021
Accounts 2021 · 2022-20466756

Events

  1. 2024
    Annual accounts 2024377,4 k €↑
  2. 2023
    Annual accounts 2023225,2 k €↑
  3. 2023
    Name changeDR. VANDEKERCKHOVE HANS, cardioloog en DR. VANDERSTRAETEN EVELYNE, klinisch-bioloog
  4. 2022
    Annual accounts 2022219,6 k €↑
  5. 2022
    Name changeDR. VANDEKERCKHOVE HANS, cardioloog en DR. VANDERSTREAETEN EVELYNE, klinisch bioloog
  6. 2021
    Annual accounts 2021198,2 k €↑
  7. 2020
    Annual accounts 202073,3 k €↑
  8. 2019
    Annual accounts 20194,7 k €↓
  9. 2018
    Annual accounts 201839,5 k €↑
  10. 2017
    Annual accounts 201728,2 k €↑
  11. 2016
    Annual accounts 201611,2 k €↓
  12. 2015
    Annual accounts 201560,9 k €↓
  13. 2014
    Annual accounts 2014111,8 k €↑
  14. 2013
    Annual accounts 201379,5 k €↓
  15. 2012
    Annual accounts 2012137,2 k €↓
  16. 2011
    Annual accounts 2011164,3 k €↓
  17. 2010
    Annual accounts 2010179,6 k €↑
  18. 2009
    Annual accounts 2009129,2 k €↓
  19. 2008
    Annual accounts 2008130 k €
  20. 27/08/2007
    IncorporationPrivate limited company